466 related articles for article (PubMed ID: 16930084)
1. Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables.
Feher G; Koltai K; Papp E; Alkonyi B; Solyom A; Kenyeres P; Kesmarky G; Czopf L; Toth K
Drugs Aging; 2006; 23(7):559-67. PubMed ID: 16930084
[TBL] [Abstract][Full Text] [Related]
2. Hemorheological background of acetylsalicylic acid resistance.
Feher G; Koltai K; Kesmarky G; Toth K
Clin Hemorheol Microcirc; 2008; 38(3):143-52. PubMed ID: 18239256
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry.
Bauriedel G; Skowasch D; Schneider M; Andrié R; Jabs A; Lüderitz B
Am Heart J; 2003 Feb; 145(2):343-8. PubMed ID: 12595854
[TBL] [Abstract][Full Text] [Related]
4. [Decreased platelet aggregation during angiotensin-converting enzyme inhibitor therapy. Results of a pilot study].
Skowasch D; Lentini S; Andrié R; Jabs A; Bauriedel G
Dtsch Med Wochenschr; 2001 Jun; 126(24):707-11. PubMed ID: 11446026
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in hemorheological parameters and in in vitro platelet aggregation in acetylsalicylic acid and clopidogrel treated vascular patients.
Koltai K; Papp J; Kenyeres P; Feher G; Tibold A; Alexy T; Marton Z; Kesmarky G; Toth K
Biorheology; 2014; 51(2-3):197-206. PubMed ID: 24898335
[TBL] [Abstract][Full Text] [Related]
6. Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia.
Szapary L; Horvath B; Marton Z; Alexy T; Kesmarky G; Habon T; Szots M; Koltai K; Juricskay I; Czopf J; Toth K
CNS Drugs; 2004; 18(3):165-72. PubMed ID: 14871160
[TBL] [Abstract][Full Text] [Related]
7. Resistance to low-dose aspirin therapy among patients with acute coronary syndrome in relation to associated risk factors.
Salama MM; Morad AR; Saleh MA; Sabri NA; Zaki MM; ElSafady LA
J Clin Pharm Ther; 2012 Dec; 37(6):630-6. PubMed ID: 23121257
[TBL] [Abstract][Full Text] [Related]
8. Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.
Nardin M; Verdoia M; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):567-574. PubMed ID: 27134063
[TBL] [Abstract][Full Text] [Related]
9. Platelet aggregation is dependent on platelet count in patients with coronary artery disease.
Würtz M; Hvas AM; Kristensen SD; Grove EL
Thromb Res; 2012 Jan; 129(1):56-61. PubMed ID: 21917303
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
[TBL] [Abstract][Full Text] [Related]
11. [Effect of atorvastatin treatment on the hemorheologic and hemostatic parameters in chronic cerebrovascular patients].
Szapáry L; Horváth B; Márton Z; Fehér G; Tóth K; Komoly S
Orv Hetil; 2008 Jun; 149(24):1117-23. PubMed ID: 18539578
[TBL] [Abstract][Full Text] [Related]
12. Aspirin in coronary artery disease: an appraisal of functions and limitations.
Würtz M
Dan Med J; 2015 Apr; 62(4):B5011. PubMed ID: 25872543
[TBL] [Abstract][Full Text] [Related]
13. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial.
; Yusuf S; Pais P; Afzal R; Xavier D; Teo K; Eikelboom J; Sigamani A; Mohan V; Gupta R; Thomas N
Lancet; 2009 Apr; 373(9672):1341-51. PubMed ID: 19339045
[TBL] [Abstract][Full Text] [Related]
14. Elderly patients undergoing major vascular surgery: risk factors and medication associated with risk reduction.
Feringa HH; Bax JJ; Karagiannis SE; Noordzij P; van Domburg R; Klein J; Poldermans D
Arch Gerontol Geriatr; 2009; 48(1):116-20. PubMed ID: 18177954
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor.
Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G;
Cardiovasc Ther; 2016 Aug; 34(4):209-15. PubMed ID: 27086085
[TBL] [Abstract][Full Text] [Related]
16. Profile and prevalence of aspirin resistance in patients with cardiovascular disease.
Gum PA; Kottke-Marchant K; Poggio ED; Gurm H; Welsh PA; Brooks L; Sapp SK; Topol EJ
Am J Cardiol; 2001 Aug; 88(3):230-5. PubMed ID: 11472699
[TBL] [Abstract][Full Text] [Related]
17. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
Béres BJ; Tóth-Zsámboki E; Vargová K; László A; Masszi T; Kerecsen G; Préda I; Kiss RG
Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527
[TBL] [Abstract][Full Text] [Related]
18. Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril.
Skowasch D; Viktor A; Schneider-Schmitt M; Lüderitz B; Nickenig G; Bauriedel G
Clin Res Cardiol; 2006 Apr; 95(4):212-6. PubMed ID: 16598590
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of use of antiplatelet drugs, beta blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in older patients with coronary artery disease in an academic nursing home.
Joseph J; Koka M; Aronow WS
J Am Med Dir Assoc; 2008 Feb; 9(2):124-7. PubMed ID: 18261706
[TBL] [Abstract][Full Text] [Related]
20. Follow-up of hemorheological parameters and platelet aggregation in patients with acute coronary syndromes.
Marton Z; Horvath B; Alexy T; Kesmarky G; Gyevnar Z; Czopf L; Habon T; Kovacs L; Papp E; Mezey B; Roth E; Juricskay I; Toth K
Clin Hemorheol Microcirc; 2003; 29(2):81-94. PubMed ID: 14610303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
